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Abstract
Myosins I were the first unconventional myosins to be purified and they remain the best characterized. They have been
implicated in various motile processes, including organelle translocation, ion channel gating and cytoskeletal reorganization
but their exact cellular functions are still unclear. All members of the myosin I family, from yeast to man, have three
structural domains: a catalytic head domain that binds ATP and actin; a tail domain believed to be involved in targeting the
myosins to specific subcellular locations and a junction or neck domain that connects them and interacts with light chains. In
this review we discuss how each of these three domains contributes to the regulation of myosin I enzymatic activity, motor
activity and subcellular localization. ß 2000 Elsevier Science B.V. All rights reserved.
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1. Introduction
In 1973 Pollard and Korn reported the discovery
of an unconventional myosin, which, unlike all other
myosins characterized at that time, was single-headed
and did not self-associate into bipolar ¢laments [1].
They further showed that this protein, Acanthamoeba
myosin I, expressed actin-activated ATPase activity
only in the presence of a V95 kDa cofactor [2],
subsequently identi¢ed as myosin I kinase [3]. De-
spite steady progress in the Korn and Pollard labo-
ratories, it took more than a decade for the uncon-
ventional myosin ¢eld to gain momentum. As noted
from the outset [4] it was essential to demonstrate
that myosin I was not merely a proteolytic fragment
of conventional myosin. This was conclusively estab-
lished by Hammer and his colleagues who cloned
Acanthamoeba myosin IB, and showed that it con-
tained a myosin-like catalytic head of about 80 kDa
and a unique tail of about 50 kDa [5,6]. At about the
same time the ¢rst non-Acanthamoeba forms of my-
osin I were identi¢ed, in microvilli of the chicken
intestinal brush border [7] and in Dictyostelium [8].
By the early 1990s it became clear that multiple
forms of myosin I exist and that these are ubiqui-
tously expressed from yeast to human (most recently
reviewed in [9]).
With the advent of facile cloning techniques and
the expansion of sequence data bases we are now
faced with a plethora of actin-dependent motor pro-
teins and a somewhat confusing nomenclature. At
present there are ¢fteen known families of myosin,
including the single family of conventional myosins,
myosins II [10]. In this review the myosin I subfamily
is divided into four classes, which we designate IK,
IL, IC and IQ. In rat these have been termed myr1,
myr2, myr3 and myr4, respectively, for myosin I
from rat [11]. In some classi¢cations the closely re-
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lated myosins IK and BBMI (brush border myosin I)
are grouped separately, giving a total of ¢ve sub-
classes. Myosin IC is the human version of yeast
and protozoan myosins I and they are sometimes
referred to as ‘amoeboid’ or ‘classical’ myosins I.
Structurally, myosins I are quite similar to each oth-
er. All have N-terminal head domains of V70^80
kDa containing actin and ATP-binding sites, K-heli-
cal neck domains containing from one to six IQ (iso-
leucine^glutamine) motifs that interact with light
chains (often calmodulin molecules) and C-terminal
tail domains of varying sizes and considerable se-
quence diversity. All myosin I tail domains have
net positive charges and many have been shown to
interact with anionic phospholipids, though some-
times only at low ionic strength [12]. The tails of
‘classical’ myosins I can be further subdivided into
proline-rich segments, Src homology 3 (SH3) do-
mains and, in some cases, ATP-independent actin-
binding domains rich in glycine, proline and alanine
residues [13^15]. The diversity among myosin I tails
is evident in Fig. 1 which shows two classical myo-
sins, Acanthamoeba myosin IC and rat myr3, and a
non-classical form, bovine myosin IL. Fig. 1 high-
lights another feature that distinguishes vertebrate
from lower eukaryotic myosins I: protozoan and
yeast myosins have a phosphorylatable residue in
the head domains whereas vertebrate forms have
negatively charged residues in the corresponding po-
sition.
This review focuses on recent advances in the reg-
ulation of myosin I enzymatic and motor activities
and in the targeting of di¡erent forms of myosin I to
speci¢c locations in the cell. Regulation can involve
interactions or modi¢cations in all three myosin I
domains. Phosphorylation in the head domain is re-
quired for stimulation of the ATPase activities of
lower eukaryotic myosins I by F-actin. The neck do-
mains of myosin I appear to function similarly to the
regulatory domains of conventional muscle-type my-
osins, serving as lever arms to control displacement
during the ATPase cycle. The length of this lever arm
may be modulated by the presence, absence, or ori-
entation of light chains that interact with the myosin
I neck. Finally, it is widely believed that subcellular
targeting is determined by interactions involving my-
osin I tails. In the case of myosin II, the tails self-
associate to form bipolar ¢laments that interact with,
and promote the sliding of, actin ¢laments, as occurs
during muscle contraction. The tails of unconven-
Fig. 1. Domain structure of myosins I. GPA: glycine, proline, alanine-rich domain; SH3: Src homology 3 domain; IQ: isoleucine,
glutamine motif. Arrows in catalytic domain indicate phosphorylatable or negatively charged residues.
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tional myosins have been referred to as ‘cargo’ do-
mains, for they presumably tether the myosins to the
cellular cargo which must be translocated along actin
¢laments. The great diversity in primary structure of
myosin tails is likely to account for speci¢c targeting
of the motors, mediated by interactions with distinct
myosin I binding proteins.
2. Regulation of myosin I activities by
phosphorylation
2.1. Myosin I kinases
We begin our discussion of myosin I regulation
with a look at heavy chain phosphorylation, even
though it is only in lower eukaryotes that the signi¢-
cance of this modi¢cation has been ascertained. The
discovery of myosin I kinase nearly coincided with
that of myosin I itself, when Pollard and Korn real-
ized that expression of high actin-stimulated ATPase
activities of Acanthamoeba myosin I required the
presence of a ‘cofactor’ protein [2]. Shortly thereafter
the cofactor was recognized as a protein kinase [3]
which was subsequently puri¢ed to homogeneity
from Acanthamoeba [16] and Dictyostelium [17] and
characterized extensively. Both kinases must undergo
autophosphorylation for enzymatic activity [18,19].
Negatively charged phospholipids increase the rate
of autophosphorylation, thereby also accelerating
myosin I phosphorylation. Ca2-calmodulin inhibits
myosin I kinase activity, evidently by competing with
phospholipids for a binding site near the amino-ter-
minus of the kinase [19,20].
Interest in these kinases surged when the Dictyo-
stelium [21] and Acanthamoeba [22] enzymes were
found to have sequence similarity to the PAK/Ste20
kinase family, implicated in cell signaling and cyto-
skeletal reorganization. The two myosin I kinases
have many features in common with each other
and with the PAK/Ste20 enzymes, but some di¡er-
ences also exist. PAK/Ste20 and myosin I kinases are
both activated by Cdc42 and Rac, members of the
p21 family of GTP-binding proteins [23]. They have
two regions of high sequence similarity: in the cata-
lytic domains, located in the C-terminal halves of the
molecules, and within the p21 binding domains
(PBDs) found in the N-terminal regulatory domains
(Fig. 2). PBDs are approximately 60 amino acid res-
idues in length. The ¢rst 14 residues comprize the
Fig. 2. Structural domain of myosin I kinases and their comparison with PAK and Ste20. PBD-p21 binding domain.
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highly conserved CRIB (Cdc42/Rac interactive bind-
ing) motif which, together with the subsequent 15^16
residues, is required for interaction with p21 pro-
teins. Like PAK or Ste20, both myosin I kinases
bind Rac/Cdc42 in a GTP-dependent manner, result-
ing in autophosphorylation and kinase regulation
[21,24].
The two myosin I kinases have low sequence sim-
ilarities outside the PBD and catalytic domains but
they share several structural features. Both have pro-
line-rich regions containing multiple PXXP motifs
characteristic for binding to Src homology 3 (SH3)
domains. These motifs may serve to strengthen inter-
actions with myosins I, many of which contain SH3
domains and to target the kinases to membrane-
bound SH3 domain-containing proteins, a mecha-
nism already demonstrated for PAK [25]. Both my-
osin I kinases also contain clusters of charged amino
acids, including a basic region N-terminal to the
PBD which mediates phospholipid binding.
Rac/Cdc42 and phospholipids are likely to stimu-
late myosin I kinase activity by reversing an auto-
inhibition that results from interactions between the
catalytic and regulatory domains of the kinases (Fig.
2). Although the autoinhibitory sites have not yet
been identi¢ed, their locations can be inferred from
studies of PAK/Ste20 regulation. Yeast two-hybrid
analysis revealed that the regulatory and catalytic
domains of Schizosaccharomyces pombe PAK can in-
teract with each other and the site of interaction was
localized to the C-terminal portion of the PBD [26]
(Fig. 3). This site partially overlaps with the binding
site for Rac/Cdc42, which presumably disrupts its
inhibitory interaction with the catalytic domain.
Zhao et al. [27] provided evidence for the autoinhi-
bition mechanism by showing that a peptide corre-
Fig. 3. Hypothetical mechanism of myosin I kinase regulation. The inactive state is maintained by an interaction between the regula-
tory and catalytic domains. The sequences shown above the scheme represent the putative interaction domain within the PBD
(hatched region) that binds to, and inhibits, the catalytic domain. Binding of Cdc42/Rac, negatively charged phospholipids or SH3 do-
main-containing proteins opens the structure and relieves the autoinhibition).
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sponding to residues 83^149 in the regulatory do-
main blocked PAK activation in vitro and in vivo
whereas mutations in residues 101^137 induced con-
stitutive kinase activity. A single point mutation
(L107F) in PAK renders the enzyme constitutively
active. Leucine 107 is conserved in Ste20 and in
Acanthamoeba and Dictyostelium myosin I kinases
and it will be interesting to see whether similar point
mutations result in constitutive myosin I kinase ac-
tivity.
To summarize, available data are consistent with
the view that all modes of myosin I kinase activation,
whether by binding to phospholipids, to Rac/Cdc42,
or by autophosphorylation in the regulatory domain,
are due to an opening of the proteins and relaxation
of autoinhibition.
2.2. E¡ects of myosin I phosphorylation
Phosphorylation of Acanthamoeba [28] and Dic-
tyostelium [8] myosins I by myosin I heavy chain
kinase is necessary for activation of their ATPase
activities by actin. Presumably this is also true of
yeast and Aspergillus myosins I but these proteins
have not yet been puri¢ed or characterized. These
lower eukaryotic myosins, as well as metazoan my-
osin VI, have phosphorylatable serine or threonine
residues at conserved positions within their catalytic
head domains. Nearly all other myosins have a neg-
atively charged residue at the corresponding position,
which resides in a £exible loop believed to be in
contact with actin [29]. Apparently, a negative
charge, whether contributed by phosphate groups
on modi¢ed serines or threonines or by aspartyl or
glutamyl side chains, is required for acceleration of
product release during the ATPase reaction [30].
Only one form of myosin, Drosophila myosin IA,
violates the so-called ‘TEDS rule’, i.e. the require-
ment for T, E, D or S residues in the conserved
loop position [31]. However, the consequences of
this di¡erence remain to be determined. The e¡ect
on the structure of myosin I of a negative charge
in the TEDS position must be subtle, since cryoelec-
tron microscopy of a constitutively active Acantha-
moeba myosin IC mutant (S329E) or an inactive mu-
tant (S329A) revealed no discernible di¡erences in
their actin^myosin interfaces [32].
There is convincing genetic evidence for the in vivo
signi¢cance of myosin I phosphorylation. In Dictyo-
stelium a double deletion of myoA and myoB impairs
growth, pinocytosis and actin organization [33].
These defects are reversed by expression of wild-
type myoB but not by mutant S332A which lacks
the TEDS phosphorylation site [34]. Likewise, in
Saccharomyces, expression of wild-type but not the
TEDS mutant S357A of Myo3p rescues budding de-
fects caused by deletion of both forms of yeast my-
osin I [35,36]. Signi¢cantly, mutant S357D also res-
cues the budding defect, demonstrating that a
negatively charged residue, as occurs in most verte-
brate myosins I, can substitute for phosphoserine or
phosphothreonine [36]. The situation is somewhat
more complicated in Aspergillus. Deletion of Asper-
gillus MYOA results in inhibition of polarized hy-
phal growth and protein secretion [37]. Expression
of non-phosphorylatable TEDS mutant S371A re-
stored all functions lost by MYOA deletion, arguing
that this modi¢cation is not essential for the cellular
activity of the Aspergillus enzyme. However, phos-
phorylation of serine 371 must somehow alter the
myosin because cells expressing mutant S371E have
increased accumulation of membranes in growing
hyphae, perhaps due to an increase in endocytosis
[38].
Despite the absence of a phosphorylatable TEDS
residue in vertebrate myosins I, it is still possible that
these enzymes are subject to regulation by phosphor-
ylation. Myosins IK (including brush border myosin
I), IL and IQ can all be phosphorylated in vitro by
protein kinase C (PKC) in yet unidenti¢ed sites in
the tail domains [39,40]. These modi¢cations appar-
ently do not a¡ect actin-activated ATPase activities
but may in£uence interactions with calmodulin and
phospholipid vesicles [39,40]. It is too early to tell
whether this type of regulation has physiological
signi¢cance, but the similarity with neuromodulin
[41], in which PKC phosphorylation also reduces
a⁄nity for calmodulin at an IQ domain, is intrigu-
ing.
3. Regulation of myosin I activity at the ‘neck’ domain
The junction between head and tail domains of
myosin I are extended K-helical structures that inter-
act with light chains, most often calmodulin mole-
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cules. There is strong evidence that the ATPase and
motor activities of most forms of myosin I are regu-
lated by interactions between light and heavy chains,
although the mechanism of regulation is poorly
understood.
Myosin I neck domains contain from one to six IQ
motifs, K-helical stretches of 20^25 amino acid resi-
dues including the consensus sequence (IVL)QXXX-
RGXXX(RK)XX(FILVWY) [42]. IQ motifs have
been identi¢ed in several proteins, including neuro-
modulin and neurogranin, where they bind to Ca2-
free calmodulin (recently reviewed in [43]). The light
chains of vertebrate and yeast myosins I are, in fact,
calmodulin molecules and the only sequenced light
chain of a protozoan myosin is a calmodulin-like
protein containing two potential helix^loop^helix
Ca2-binding domains [44]. In most cases myosin I
IQ motifs bind more tightly to apocalmodulin than
to Ca2/calmodulin. An exception is rat myosin IQ
(myr4) which contains two IQ motifs in the neck
domain with di¡erent a⁄nity for Ca2 : one, the C-
terminal, binds calmodulin tightly in the presence of
Ca2 and the second, the N-terminal, binds calmod-
ulin more strongly in the absence of Ca2 [45]. The
structure of the complex between calmodulin and a
myosin I IQ domain has not yet been determined.
However, Houdusse et al.[46] have modeled the
likely interactions between calmodulin and the ¢rst
IQ domain of brush border myosin I, based on mo-
lecular contacts found in the crystal structure of the
scallop myosin regulatory domain. Calmodulin has
two high-a⁄nity Ca2-binding sites in its C-terminal
lobe and two low-a⁄nity sites in its N-terminal lobe.
The lobes adopt a closed conformation in the ab-
sence of Ca2 and an open conformation when
Ca2 is bound [47]. According to the model of Hou-
dusse et al. [46], the C-terminal lobe of apocalmodu-
lin adopts a ‘semi-open’ conformation that can grip
the most N-terminal segment of the IQ domain
(IQXXXR). The N-terminal (low Ca2-a⁄nity)
lobe of calmodulin binds weakly to the myosin heavy
chain. Upon binding Ca2, the C-terminal lobe
changes to an open conformation, reducing its a⁄n-
ity for the N-terminal portion of the IQ domain,
leading either to dissociation of calmodulin or its
binding to a di¡erent set of sites on the IQ motif.
This alternative binding mode may be similar to the
conventional amphipathic helix interaction that oc-
curs in most proteins that bind preferentially to
Ca2/calmodulin. There is evidence that release of
calmodulin is not essential for the regulation of my-
osin I activity; allosteric changes due to Ca2 liga-
tion of calmodulin are su⁄cient [48].
Houdusse et al. [46] noted that tandemly repeated
IQ motifs of unconventional myosins vary in length
from 22 to 36 residues. Thus, calmodulins may adopt
di¡erent spacings and orientations with respect to
each other, perhaps accounting for observed di¡er-
ences in the Ca2 sensitivity of their binding to my-
osin heavy chains. Variations in IQ domains among
the di¡erent myosins may also explain the non-uni-
formity of Ca2 e¡ects on ATPase activities. Ca2
has been reported to stimulate [49,50], inhibit
[48,51] or have essentially no e¡ect [52^54] on
Mg2-ATPase activities of myosins I assayed in the
presence of actin. In many studies, kcat values of the
Mg2-ATPase reaction are increased by Ca2 both in
the absence and the presence of actin. Hence, sub-
traction of basal activities often result in negligible or
even inhibitory e¡ects of Ca2 on actin-activation,
even if overall turnover numbers are higher in the
presence than in the absence of Ca2.
While Ca2 has diverse e¡ects on the ATPase ac-
tivities of myosins I, it invariably inhibits their ability
to translocate actin in in vitro motility assays [50,52^
54]. By analogy with myosin II, IQ domains are be-
lieved to act as lever arms that increase the displace-
ment of the power stroke during myosin motor ac-
tivity ([55] recently reviewed in [56]). The speed of
actin translocation is directly proportional to the
length of the lever arm. It is conceivable that Ca2-
induced release or rearrangement of calmodulin light
chains alters the myosin I neck in a manner that
prevents lever arm movement. In the model of Hou-
dusse et al. [46] the IQ domain^apocalmodulin com-
plex is an elongated structure, with about 30 residues
of the IQ motif stabilized by calmodulin, compared
to only about 20 residues typically stabilized in tar-
gets complexed with Ca2-calmodulin. This implies
that the myosin neck becomes more compact in the
presence of Ca2. Indeed, cryoelectron microscopy
and image analysis of brush border myosin I showed
that the calcium-induced loss of calmodulin triggers
an extensive reorganization of mass within the tail
domain whereas the catalytic head domain does not
undergo signi¢cant changes [57]. In the presence of
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calcium, the tail is approximately ovoid with a long
axis of 60 Aî . In the absence of calcium, however, this
domain has more elongated appearance, extending
an additional 20 Aî .
The in vivo signi¢cance of IQ motifs as regulatory
elements of myosin I function is currently being ex-
amined using molecular genetic approaches. In Sac-
charomyces, receptor-mediated endocytosis of K-mat-
ing factor requires calmodulin, although the Ca2-
binding property of calmodulin is not essential for
this function [58]. Therefore, proteins which were
known to interact with Ca2-free calmodulin, such
as myosin I, were considered likely co-participants
in this process. Indeed, endocytosis is blocked in
yeast cells lacking both myosin I genes, but can be
rescued by expression of Myo5p alone in the double
knockouts [59]. Expression of a mutant Myo5p lack-
ing both IQ motifs was also capable of rescuing en-
docytosis in the double knockouts [60], indicating
that the enzyme is functional without a neck domain.
This result was interpreted by the author as suggest-
ing that the neck region of Myo5p functions as an
autoinhibitory domain and that inhibition is reversed
by binding of calmodulin.
In contrast to the Saccharomyces results, deletion
of the IQ domain of MYOA in Aspergillus has a
profound impact on the growth of this ¢lamentous
fungus. The IQ-deleted mutant strain produced much
smaller colonies than cells expressing wild type
MYOA and generally induced a variety of morpho-
logical defects including thickened cell walls, shorter
and wider hyphal compartments and multiple germ
tubes [61]. It has been con¢rmed that MYOA inter-
acts with calmodulin and that the IQ motif is the site
of calmodulin binding.
As evident from the above discussion it is still too
early to assess the physiological consequences of Ca/
calmodulin binding to myosin I. In vivo studies are
very limited but in vitro studies, based mainly on
motility assays, indicate that Ca2 binding inhibits
the motor activity of vertebrate myosin I. If this in-
hibition also occurs in vivo then these myosins would
presumably be inactive when intracellular Ca2 rises
to micromolar levels as it does in response to many
extracellular stimuli. The precise functions of myo-
sins I will have to be determined before we can
understand why their motor activities should be in-
hibited under cell stimulatory conditions.
4. Targeting: a role for the myosin I tail domain
At present there is scant evidence for the regula-
tion of vertebrate forms of myosin I by phosphory-
lation and there is disagreement concerning their reg-
ulation by Ca2 and calmodulin. Thus it is possible
that these motors are constitutively active catalyti-
cally and that their cellular functions are controlled
by targeting them to appropriate subcellular loca-
tions and cargo. The mechanism of myosin I target-
ing is not yet understood. As indicated in Table 1,
these myosins have been found in nearly all organ-
elles and, most frequently, in specialized structures at
the cell periphery. Although individual myosin types
are often found in multiple locations in the same cell,
there is enough selectivity to preclude relatively non-
speci¢c targeting mechanisms such as the well-estab-
lished interactions between myosin I tails and anionic
phospholipid headgroups [12]. For example, myosin
IL is enriched at the plasma membrane but excluded
from secretory vesicle membranes in adrenal chro-
ma⁄n cells (our unpublished observations), even
though vesicle membranes are negatively charged
and contribute 10 times the available surface area
as plasma membranes [62]. Hence, one of the most
active areas of current research in myosin I, and
other unconventional myosins, is the search for
docking proteins or receptors, as well as the search
for targeting determinants within the myosin mole-
cules.
In the so-called protozoan class of myosin I (my-
osin IC in our nomenclature), attention has focused
on the role of the SH3 domain, typically found at or
near the C-termini of these myosins. Two putative
binding partners have been found for myosin I
SH3 domains. The ¢rst, a soluble protein from Acan-
thamoeba known as Acan125, binds to the SH3 do-
main of Acanthamoeba myosin IC [63] and colocal-
izes with it to the same intracellular organelles.
Acan125 has a proline-rich segment near the C-ter-
minus that includes tandem PXXP motifs character-
istic of SH3 domain-binding proteins. In addition, it
contains leucine-rich repeats (LRR) found in a vari-
ety of signaling proteins [64]. Thus, Acan125 may be
an adaptor molecule that links myosin I to a yet
unidenti¢ed LRR-binding protein, perhaps one
which resides on a target membrane [65].
The second putative myosin I ‘receptor’ is verpro-
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lin, an actin-binding protein of Saccharomyces that
contains eleven potential SH3 domain interaction
motifs [66,67]. Verprolin was shown to interact
both with Myo3p and Myo5p by two-hybrid screen-
ing, co-localizes with Myo5p in cortical patches, and
co-immunoprecipitates with Myo5p from yeast cell
extracts [68]. Although Myo5p patches can form in
the absence of verprolin, they no longer localize to
sites of polarized cell growth, suggesting that verpro-
lin plays a role in myosin I targeting in yeast.
There is no strong evidence yet for the existence of
a binding partner for the SH3 domain of vertebrate
myosin IC (myr3). However, this myosin was identi-
¢ed in a yeast two-hybrid screen to ¢nd proteins that
may interact with the proto-oncogene product c-Cbl
[69]. The c-Cbl protein, which contains a proline-rich
SH3-domain binding region, is a negative regulator
of lymphocyte signaling [70] and is tyrosine
phosphorylated upon stimulation of (among others)
B-cell and T-cell receptors [71]. Interestingly, the
chicken version of myosin IC (called chicken myosin
IB), is most highly expressed in lymphoid tissues [72].
The evidence that SH3 domains are involved in
subcellular targeting is mixed. Strongest support for
such a role has emerged from genetic studies in Sac-
charomyces. In normal yeast actin is organized into
cables polarized toward the site of bud formation
and in punctate cortical patches in the buds. Deletion
of Myo3p and Myo5p causes severe defects in polar-
ization of the actin cytoskeleton and, as stated
above, in processes such as secretion and endocytosis
which depend on the cytoskeleton [35,59]. Whereas
expression of wild type Myo5p fully restores these
functions, a mutant Myo5p lacking the SH3 domain
does so only partially [68]. Moreover, the mutant
myosin does not properly localize at sites of polar-
Table 1
Subcellular distribution of myosins I
Myosin Location References
Acanthamoeba
Myosin IA cytoplasm; beneath phagocytic cups on plasma membranes and in small
cytoplasmic vesicles
[86]
Myosin IB plasma membrane; large vacuolar phagocytic membranes [86]
Myosin IC contractile vacuolar membranes [87]
Dictyostelium
myoB and myoD lamellipodia; regions of cell^cell contact [88]
Aspergillus nidulans
MyoA cytoplasm; growing hyphal tips (punctate) [37]
Saccharomyces cerevisiae
Myo 5p patches concentrated in buds [35]
Vertebrate :
Brush border MI (bovine and
avian)
intestinal microvillus [89]
Golgi-derived vesicles [90]
Myosin IK/myr1 plasma membrane (particularly cell projections); cleavage furrow of dividing cells [74]
endosomes and lysosomes [79]
neuronal growth cones [91]
zymogen granule membranes [92]
Myosin IL/myr2 cell periphery/plasma membrane with some cytoplasmic punctate staining [74,93]
nucleus [94]
phagocytic cups [95]
mitochondria in photoreceptor cells [96]
auditory hair cells [97]
microvilli of kidney cells [98]
Myosin IC/myr3 (chicken
myosin IB)
cytoplasm and regions of cell^cell contact [73,99]
phagocytic membranes [78]
Myosin IQ/myr4 membranes in neuronal cell bodies and dendrites [45]
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ized cell growth. Similarly, expression in Dictyoste-
lium of mutant myoB lacking the SH3 domain fails
to rescue defects in growth, endocytosis and cytoskel-
etal organization in myoA3/myoB3 double mutants
[34]. In this case, however, deletion of the SH3 do-
main did not cause improper localization. Further
evidence against the SH3 domain as a targeting de-
terminant is the observation that deletion of the SH3
domain of Aspergillus MYOA has no e¡ect on cell
growth, morphology, secretion or endocytosis [61]. A
similar deletion in rat myr3 also has no a¡ect on its
localization to cell^cell junctions in HeLa cells [73].
In Aspergillus MYOA the essential portion of the tail
is a proline-rich region just beyond the SH3 domain;
in myr3 the site required for proper targeting is just
prior the SH3 domain, though the catalytic head
domain apparently also participates in myosin local-
ization.
The possibility that SH3 domains are involved in
regulation of ATPase activity rather than, or in ad-
dition to, targeting must also be considered. For ex-
ample, these domains may be sites of interaction with
myosin I kinases which, as mentioned above, contain
multiple PXXP motifs. Alternatively, SH3 domains
may participate in intramolecular rather than inter-
molecular interactions, perhaps folding back and
binding to proline-rich regions often found in myosin
I tails. Indeed, Sto¡er and Bahler [48] have shown
that a proteolytically truncated myr3 lacking approx-
imately 10 kDa from the C-terminus (including the
SH3 domain) expresses a 2^3-fold higher Mg2-
ATPase activity, suggesting an intramolecular, auto-
inhibitory, mode of regulation similar to that found
in some Src family members.
With the exception of human myosin IC/myr3,
vertebrate myosins I lack SH3 domains, or other
established protein^protein interaction domains.
However, it is clear that even in these myosins the
targeting determinants are found within the C-termi-
nal tails [74].
Based on kinetic arguments it has been speculated
that some forms of myosin I do not bind individually
to their cargo but instead must exist as clusters on
membrane surfaces [30,75]. Otherwise, given the
small portions of the ATPase cycle in which the my-
osins are strongly attached to actin, the myosins and
their cargo would tend to di¡use away before trans-
location can occur. Interestingly, clusters of approx-
imately 50^100 molecules of myosin IL have been
visualized by electron microscopy in auditory hair
cell stereocilia [76]. The authors of that study suggest
that the myosins are gathered together on a putative
‘raft’ or sca¡old molecule that is itself tethered to
cargo, in this case ion channels, on the plasma mem-
brane. A multivalent myosin I sca¡old or adaptor
molecule would allow the translocation of multiple
types of proteins, perhaps concentrated in membrane
subdomains, by a single class of myosin I.
5. Conclusion
As evident from this and earlier reviews, a great
deal is known about myosin I ATPase and contrac-
tile activities and their regulation. Unfortunately, our
understanding of the functions of myosin I in cells is
far less complete. Gene knockout experiments de-
scribed above have demonstrated a clear connection
between the activities of some forms of myosin I and
proper organization of the actin cytoskeleton. Be-
cause membrane tra⁄cking often depends upon the
integrity of the actin cytoskeleton [77] it is di⁄cult to
cite clearcut examples of myosin I molecules acting
directly as motors for organelle translocation. Thus
far, speculations about myosin I functions have been
based primarily on their subcellular locations. For
example, myosin IL is found at both ends of the
tip links of auditory hair cell stereocilia, implicating
this motor in the movement or gating of ion channels
within the plasma membrane [76]. Myosin IC is
present on phagosomes, suggesting a role in actin-
dependent pinching o¡ of plasma membrane during
phagocytosis [78]. Myosin IK has been localized to
endosomes and its participation in endocytosis was
recently suggested in mammalian cells using a dom-
inant negative approach [79]. In recent years muta-
tions in several unconventional myosins have been
linked to a variety of diseases. Striking examples in-
clude the association of myosin III mutations with
retinal dysfunction [80,81], myosin V mutations with
dilute coat color and neurological defects in mice [82]
and myosin VI and VII mutations with deafness and
vestibular disorders [83^85]. Thus, elucidation of the
functions of myosin I may eventually emerge, not
from deliberate interventions (e.g. by gene knockout
or overexpression of mutants) but rather from the
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unanticipated identi¢cation of myosin I gene muta-
tions as etiological factors of known disorders.
6. Note added in proof
Two recent reports demonstrate an interaction be-
tween the Arp2/3 complex, involved in actin poly-
merization on membranes, and an acidic region in
the tails of yeast Myo3A and Myo3B [M. Evange-
lista, B.M. Klebl, A.H.Y. Tong, B.A. Webb, T.
Leeuw, E. Leberer, M. Whiteway, D.Y. Thomas,
C. Boone, A role for myosin-I in actin assembly
through interactions with Vrp1p, Bee1p, and the
Arp2/3 complex, J. Cell. Biol. 148 (2000) 353^362;
T. Lechler, A. Shevchenko, A. Shevchenko, R. Li,
Direct involvement of yeast type I myosins in
Cdc42-dependent actin polymerization, J. Cell. Biol.
148 (2000) 363^373].
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